NexPlasmaGen’s CPJ breast cancer in vivo preclinical trials completed
NexPlasmaGen is proud to announce that the preclinical trials program led by Dr. Philip Wong at the Centre Hospitaller de l’Université de Montréal...
03 November, 2021
/ 0 Comments